Silverback Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Silverback Therapeutics, Inc. | SBTX - NASDAQ |
$19.00-$20.00 | $21.00 | $29.00 | 11.5 million | 12/4/2020 |
| Goldman Sachs, SVB Leerink, Stifel | ||||||
Co-Manager(s): H.C. Wainwright & Co. | ||||||
| Health Care | ||||||
Filing(s): Filed 2020-11-10 Terms Added 2020-11-30 Terms Changed 2020-12-03 | ||||||
Silverback Therapeutics, Inc. Quote & Chart - Click for current quote - SBTX
IPO Boutique aggregates information on public companies and private companies, such as "SBTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Silverback Therapeutics, Inc. (adapted from Silverback Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company with one product candidate in a Phase 1/1b clinical trial, and they are focused on leveraging their proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company with one product candidate in a Phase 1/1b clinical trial, and they are focused on leveraging their proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SBTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.